更正：拉德万-普拉格沃夫斯卡等人。基于壳聚糖的新型支架在通过组织工程治疗盆腔器官脱垂（POP）中的潜力。2020年，，4280。
Correction: Radwan-Pragłowska et al. The Potential of Novel Chitosan-Based Scaffolds in Pelvic Organ Prolapse (POP) Treatment through Tissue Engineering. 2020, , 4280.
作者信息
Radwan-Pragłowska Julia, Stangel-Wójcikiewicz Klaudia, Piątkowski Marek, Janus Łukasz, Matýsek Dalibor, Kot Marta, Majka Marcin, Amrom Dalia
机构信息
Department of Biotechnology and Physical Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24 Street, 31-155 Cracow, Poland.
Gynecology and Oncology Department, Jagiellonian University Collegium Medicum, Kopernika 23, 31-501 Kraków, Poland.
出版信息
Molecules. 2025 Aug 12;30(16):3349. doi: 10.3390/molecules30163349.
Abstract
"Marta Kot" was not included as an author in the original publication [...].
摘要
“玛尔塔·科特”未被列入原始出版物的作者名单中[...]。
相似文献
1
Correction: Radwan-Pragłowska et al. The Potential of Novel Chitosan-Based Scaffolds in Pelvic Organ Prolapse (POP) Treatment through Tissue Engineering. 2020, , 4280.更正：拉德万-普拉格沃夫斯卡等人。基于壳聚糖的新型支架在通过组织工程治疗盆腔器官脱垂（POP）中的潜力。2020年，，4280。
Molecules. 2025 Aug 12;30(16):3349. doi: 10.3390/molecules30163349.
2
The Potential of Novel Chitosan-Based Scaffolds in Pelvic Organ Prolapse (POP) Treatment through Tissue Engineering.新型壳聚糖基支架在经组织工程治疗盆腔器官脱垂（POP）中的潜力。
Molecules. 2020 Sep 18;25(18):4280. doi: 10.3390/molecules25184280.
3
Transvaginal Mesh Versus Native Tissue Repair for Anterior and Apical Pelvic Organ Prolapse.经阴道网片与天然组织修复治疗盆腔器官前壁和顶端脱垂的比较
J Obstet Gynaecol Can. 2024 Nov;46(11):102658. doi: 10.1016/j.jogc.2024.102658. Epub 2024 Sep 12.
4
Twelve Month Outcomes of Pelvic Organ Prolapse Surgery in Patients With Uterovaginal or Posthysterectomy Vaginal Prolapse Enrolled in the Multicenter Pelvic Floor Disorders Registry.纳入多中心盆底功能障碍登记处的子宫阴道脱垂或子宫切除术后阴道脱垂患者盆底器官脱垂手术的12个月结局
Urogynecology (Phila). 2023 Oct 1;29(10):787-799. doi: 10.1097/SPV.0000000000001410.
5
Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.针对患有或未患有压力性尿失禁的盆腔器官脱垂女性的手术。
Cochrane Database Syst Rev. 2018 Aug 19;8(8):CD013108. doi: 10.1002/14651858.CD013108.
6
Where to for pelvic organ prolapse treatment after the FDA pronouncements? A systematic review of the recent literature.在美国食品药品监督管理局（FDA）发布相关声明后，盆腔器官脱垂的治疗何去何从？近期文献的系统综述
Int Urogynecol J. 2013 May;24(5):707-18. doi: 10.1007/s00192-012-2025-3. Epub 2013 Jan 10.
7
Perioperative interventions in pelvic organ prolapse surgery.盆腔器官脱垂手术的围手术期干预措施。
Cochrane Database Syst Rev. 2025 Jul 22;7(7):CD013105. doi: 10.1002/14651858.CD013105.pub2.
8
Closing the gap: addressing delayed healthcare-seeking and improving quality of life for Ethiopian women with pelvic organ prolapse.
Eur J Obstet Gynecol Reprod Biol. 2025 Sep;313:114597. doi: 10.1016/j.ejogrb.2025.114597. Epub 2025 Jul 22.
9
[Safety and long-term efficacy of transvaginal reconstructive pelvic surgery for severe pelvic organ prolapse in elderly women aged 70 years and over].[经阴道重建盆腔手术治疗70岁及以上老年女性严重盆腔器官脱垂的安全性和长期疗效]
Zhonghua Fu Chan Ke Za Zhi. 2025 Aug 25;60(8):627-636. doi: 10.3760/cma.j.cn112141-20250220-00058.
10
Outcome reporting in trials on conservative interventions for pelvic organ prolapse: A systematic review for the development of a core outcome set.针对盆腔器官脱垂的保守干预措施的试验中的结局报告：制定核心结局集的系统评价。
Eur J Obstet Gynecol Reprod Biol. 2022 Jan;268:100-109. doi: 10.1016/j.ejogrb.2021.08.028. Epub 2021 Aug 28.
本文引用的文献
1
The Potential of Novel Chitosan-Based Scaffolds in Pelvic Organ Prolapse (POP) Treatment through Tissue Engineering.新型壳聚糖基支架在经组织工程治疗盆腔器官脱垂（POP）中的潜力。
Molecules. 2020 Sep 18;25(18):4280. doi: 10.3390/molecules25184280.
Zotero 插件